Alessandro Di Giovanni
Biographic Data
| ID | 7967562 |
|---|---|
| NAME | Alessandro Di Giovanni |
| GIVEN NAMES | Alessandro |
| FAMILY NAME | Di Giovanni |
| SIGNATURE | DI GIOVANNI A |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Brexpiprazole in patients with schizophrenia with or without substance use disorder
Treatment with brexpiprazole for 6 months improved psychotic symptoms in patients with schizophrenia, independently from whether they belonged to the SUD or the non-SUD group; hence, SUD comorbidity did not confer treatment resistance to brexpiprazole. Furthermore, in the SUD group, we observed reduced substance craving
No prominent works on this page.
Brexpiprazole in patients with schizophrenia with or without substance use disorder
Treatment with brexpiprazole for 6 months improved psychotic symptoms in patients with schizophrenia, independently from whether they belonged to the SUD or the non-SUD group; hence, SUD comorbidity did not confer treatment resistance to brexpiprazole. Furthermore, in the SUD group, we observed reduced substance craving
Addiction (1 work) · Agonist (1 work) · Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (1 work) · Brief Psychiatric Rating Scale (1 work) · Craving (1 work) · Internal Medicine (1 work) · Medicine (1 work) · Neurotransmitter Receptor Influence on Behavior (1 work) · Observational study (1 work) · Partial agonist (1 work)